If this newsletter is not properly displayed, please click here.  
 

June 2020

 
 

Webinars on gene- and cell-therapy projects presented by Ascenion & Oxford University Innovation

Join us on 24 June and on 1 July 2020 for our webinars, presenting the top licensable projects in the field of gene and cell therapy from Ascenion’s and Oxford University Innovation’s (OUI) portfolios.

 

Read more 

 

 

Webinare zu gen- und zelltherapeutischen Projekten von Ascenion & Oxford University Innovation

Am 24. Juni und 1. Juli 2020 werden Ascenion und Oxford University Innovation (OUI) im Rahmen von Webinaren ihre besten lizenzierbaren Projekte auf dem Gebiet der Gen- und Zelltherapie präsentieren.
Seien Sie dabei!

 

Weiterlesen
 
 
 

Latest Technology Offers

15-00648

  |   AAV Vector Variants for Ocular Gene Delivery »

15-00366

  |   LncRNA LIPCAR predicts disease progression in heart failure and myocardial infarction patients »

Stay informed about new technologies in your field of interest. Register now

 
 
 
 

Meet Us

» BioJapan 2020, 14-16 October 2020, Pacifico Yokohama, Japan

» BioFIT 2020, 1-2 December 2020, Strasbourg, France

» AUTM Annual Meeting, 14-17 March 2021, Seattle, Washington, USA

» BioVaria 2021, 26-27 April 2021, Munich, Germany
 
 
 
 

Contact Us
 

Ascenion GmbH
Stanislava Zollner
E: zollner@ascenion.de
T: +49 (0)89 318814-14

 
 
 

Ascenion GmbH
Herzogstraße 64, 80803 Munich, Germany

Represented by Dr Christian A. Stein (CEO)
Register Court: Amtsgericht München HRB 118236
VAT Identification Number: DE 812299325
 

Unsubscribe | Abmelden

twitter    Social media    Instagram